Insights on Novel Technology in Pain Management with Abuse-Deterrent Extended-Release Opioids

Sponsored by Collegium Pharmaceutical, Inc.

This activity is not certified for credit.

Tuesday, September 4

Start Time

End Time

Brera Ballroom
Level 3

Program Description
With a substantial number of patients suffering from chronic pain, Collegium is committed to developing and commercializing products that help address the problems associated with non-medical use, abuse and misuse of prescription products by leveraging the Company's proprietary DETERx® technology platform.

DETERx technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have a narrow therapeutic index that would benefit from protection against misuse such as breaking, crushing, grinding, or dissolving the product.

This program will discuss key issues around opioid abuse, misuse, and diversion. An overview of opioid formulations with abuse-deterrent properties will be provided before featuring a profile of the technology that makes up the DETERx microsphere delivery system.

DETERx is a registered trademark of Collegium Pharmaceutical, Inc.

Jonathan Clapp, MD, MS

Contact Name
Alex Wriedt

Contact Phone
(617) 750-8828

Contact email


Related Content